Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Eventually stocks get so cheap compared to their growth rates that you have to act, Jim Cramer told his Mad Money viewers Tuesday. But in the case of the drug and biotech stocks, they're still getting cheaper.
Cramer said the concern over outrageous drug pricing is only growing larger and the drug stocks are competing with the oil patch for the prize of the worst sector in the entire market.
No company seems to be immune to the selling, Cramer said, as investors ponder whether the pricing challenge could be for real and long-lasting.
Cramer said that ultimately these pullbacks are a normal part of the boom and bust cycle of which high-growth names are a part. Eventually, shares will become so cheap that investors will have to step up and buy. Unfortunately, we're not yet at that level, so investors need to continue sitting on the sidelines when it comes to anything related to health care.
Is it time to circle back to the cyber security stocks, those once-loved high-fliers that have been decimated over the past few weeks? Cramer said he's not yet ready to call a bottom in the group, but said these names are relative bargains compared to where they used to trade.
Among Cramer's favorites was Palo Alto Networks (PANW - Get Report) , down 13% from its July highs. Investors will never get this stock at a market multiple, Cramer noted, so this may be the best level you'll find.
FireEye (FEYE - Get Report) has fallen 44% from its highs, thanks in part to the fact that it is not yet profitable. But the stock still made Cramer's watch list, as did CyberArc (CYBR - Get Report) , down 30% from its peak.
Cramer also gave the nod to Cisco Systems (CSCO - Get Report) , a stock he owns for his charitable trust, Action Alerts PLUS. Cisco currently trades at just 11 times earnings and has a 3% dividend yield.
A Tale of Two CEOs
It always comes down to the numbers, Cramer told viewers. That's why Pepsico (PEP - Get Report) CEO Indra Nooyi is considered best in class, while DuPont's (DD - Get Report) Ellen Kullman was forced to resign.
Cramer explained that activist investor Nelson Peltz took an interest in both companies recently. Pepsico welcomed Peltz and explained that splitting the company into two was not the best strategy for Pepsi. The was followed today by another strong quarter that sent shares up 1.3%.
Meanwhile, DuPont fought Peltz's suggestions, and after today's poor results Kullman resigned and shares soared up 7.6% on news of her exit. One can only imagine what could have been had Kullman not been so stubborn as to listen to what Peltz had to say.
Off the Charts
Using a daily chart of Microsoft, Lang noted that the stock has quietly outperformed the markets over the past six weeks, with the Chaikin money flow showing that big money managers have been accumulating. The relative strength indicator, or RSI, is also positive and the stock has made a series of higher highs and higher lows.
Lang said that Microsoft is in a "fat tail" zone, indicating price acceleration and velocity.
As for Intel, Lang said after a lackluster beginning to the year, shares of Intel have been exploding since its lows on Aug 24. The MACD momentum indicator signaled a bullish crossover earlier this month and the stock is displaying a inverse head-and-shoulders pattern, which is extremely bullish.
Executive Decision: Susan Devore
Devore said there is still a lot of savings to be had in the health care industry, up to 33% in some cases, which is why Premier is working every day to help the 120 million patients it serves.
Premier helps create competitive friction between companies to drive down costs, Devore said, and combines clinical information with pricing information to help determine the best standard of care, improving quality and safety while reducing the cost of supplies.
Health care remains a fragmented market, Devore noted, and government can't solve the issues by themselves, nor can the insurers. It takes people on the front lines, she said, and that's Premier.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.